Abstract
Five babies who presented with supraventricular tachycardia were treated with verapamil intravenously. All developed severe hypotension and two died. Verapamil should not be used in the initial management of supraventricular tachycardia in neonates.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Epstein M. L., Kiel E. A., Victorica B. E. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics. 1985 Apr;75(4):737–740. [PubMed] [Google Scholar]
- Kieval J., Kirsten E. B., Kessler K. M., Mallon S. M., Myerburg R. J. The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol. Circulation. 1982 Apr;65(4):653–659. doi: 10.1161/01.cir.65.4.653. [DOI] [PubMed] [Google Scholar]
- Orr G. M., Bodansky H. J., Dymond D. S., Taylor M. Fatal verapamil overdose. Lancet. 1982 Nov 27;2(8309):1218–1219. doi: 10.1016/s0140-6736(82)91233-8. [DOI] [PubMed] [Google Scholar]
- Wilkinson J. L. Management of paroxysmal tachycardia. Arch Dis Child. 1983 Dec;58(12):945–946. doi: 10.1136/adc.58.12.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Worthley L. I. Treating adverse effects of verapamil. JAMA. 1984 Sep 7;252(9):1129–1129. [PubMed] [Google Scholar]